Skip to main content

Want a detailed portfolio tracker?

Mersana Therapeutics (MRSN) Income Statement (2016 - 2025)

Income Statement report data from Jun 30, 2016 to Sep 30, 2025 for Mersana Therapeutics (MRSN).

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Reported currency: USD
Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Sep 30, 2016Jun 30, 2016
Revenue and COGS
Total Revenue
11M
(+259.80%)
3.06M
(+11.27%)
2.75M
(-83.19%)
16M
(+29.84%)
13M
(+450.22%)
2.29M
(-75.22%)
9.24M
(-13.64%)
11M
(+38.96%)
7.70M
(-27.70%)
11M
(+36.54%)
7.80M
(-46.90%)
15M
(+163.73%)
5.57M
(+30.14%)
4.28M
(+109.80%)
2.04M
(+20300.00%)
10K
(0.00%)
10K
(0.00%)
10K
(0.00%)
10K-10K
(-98.75%)
800K
(+7900.00%)
10K-840K
(+320.00%)
200K
(-99.51%)
41M-2.15M
(-48.69%)
4.19M
(+36.93%)
3.06M
(-6.13%)
3.26M
(-48.01%)
6.27M
(+68.10%)
3.73M
(-13.05%)
4.29M
(+31.60%)
3.26M
(-47.59%)
6.22M
Operating Expenses
Research And Development
12M
(-24.91%)
16M
(-11.56%)
18M
(-17.72%)
22M
(+50.61%)
15M
(-14.20%)
17M
(-7.70%)
19M
(-13.07%)
22M
(-29.58%)
31M
(-37.66%)
49M
(+3.57%)
47M
(+3.43%)
46M
(-9.74%)
51M
(+22.82%)
41M
(+15.14%)
36M
(-4.17%)
37M
(+5.92%)
35M
(+10.39%)
32M
(+16.56%)
27M-17M
(+7.40%)
15M
(+26.10%)
12M-14M
(-0.51%)
14M
(-9.05%)
15M-15M
(+19.91%)
13M
(+3.26%)
12M
(-15.80%)
15M
(+27.61%)
11M
(+7.34%)
11M
(+5.14%)
10M
(+33.73%)
7.56M
(-7.47%)
8.17M
Selling General And Administrative
6.30M
(-15.09%)
7.42M
(-16.91%)
8.93M
(+0.45%)
8.89M
(-9.84%)
9.86M
(-6.10%)
11M
(-9.17%)
12M
(+14.12%)
10M
(-21.41%)
13M
(-29.14%)
18M
(-0.76%)
18M
(+23.77%)
15M
(+1.65%)
15M
(-1.55%)
15M
(+15.81%)
13M
(+19.78%)
11M
(+5.43%)
10M
(+13.96%)
8.88M
(+23.16%)
7.21M-5.88M
(+13.73%)
5.17M
(+4.66%)
4.94M-4.44M
(+5.97%)
4.19M
(-5.63%)
4.44M-4.38M
(+3.55%)
4.23M
(+18.49%)
3.57M
(+16.67%)
3.06M
(+5.15%)
2.91M
(+32.27%)
2.20M
(-4.35%)
2.30M
(+43.75%)
1.60M
(-12.57%)
1.83M
Operating Expenses
19M
(-32.25%)
28M
(+1.10%)
27M
(-12.51%)
31M
(+26.35%)
25M
(-11.10%)
28M
(-8.26%)
30M
(-5.85%)
32M
(-37.78%)
52M
(-23.11%)
67M
(+2.38%)
66M
(+8.41%)
61M
(-7.21%)
65M
(+16.38%)
56M
(+15.31%)
49M
(+1.14%)
48M
(+5.81%)
45M
(+11.17%)
41M
(+17.97%)
35M-22M
(+8.99%)
21M
(+19.93%)
17M-18M
(+1.00%)
18M
(-8.32%)
20M-20M
(+15.81%)
17M
(+6.70%)
16M
(-10.11%)
18M
(+22.97%)
14M
(+11.61%)
13M
(+3.47%)
12M
(+35.52%)
9.15M
(-8.50%)
10M
Depreciation And Amortization
--320K
(-73.55%)
1.21M--420K
(-65.00%)
1.20M--320K
(-55.56%)
720K--210K
(-66.67%)
630K--230K---250K---340K---260K
(-63.89%)
720K--210K--
Operating Income
Ebit
-7.54M
(-68.97%)
-24.30M
(+0.75%)
-24.12M
(+59.52%)
-15.12M
(+36.46%)
-11.08M
(-54.35%)
-24.27M
(+32.62%)
-18.30M
(-1.08%)
-18.50M
(-54.48%)
-40.64M
(-23.72%)
-53.28M
(-3.44%)
-55.18M
(+25.52%)
-43.96M
(-25.40%)
-58.93M
(+14.52%)
-51.46M
(+10.60%)
-46.53M
(-3.06%)
-48.00M
(+5.80%)
-45.37M
(+11.15%)
-40.82M
(+17.98%)
-34.60M
(+19.97%)
-28.84M
(+28.75%)
-22.40M
(+13.71%)
-19.70M
(+16.98%)
-16.84M
(+3.63%)
-16.25M
(-2.58%)
-16.68M
(-2.06%)
-17.03M22M-22.43M
(+31.40%)
-17.07M
(+38.22%)
-12.35M
(-0.40%)
-12.40M
(-11.24%)
-13.97M
(+80.72%)
-7.73M
(-13.63%)
-8.95M
(+11.04%)
-8.06M
(+38.01%)
-5.84M
(+54.91%)
-3.77M
EBITDA
-7.15M
(-69.73%)
-23.62M
(+2.56%)
-23.03M
(+91.76%)
-12.01M
(+18.91%)
-10.10M
(-56.62%)
-23.28M
(+30.20%)
-17.88M
(+3.35%)
-17.30M
(-57.43%)
-40.64M
(-23.72%)
-53.28M
(-2.88%)
-54.86M
(+26.87%)
-43.24M
(-26.62%)
-58.93M
(+14.52%)
-51.46M
(+11.07%)
-46.33M
(-2.20%)
-47.37M
(+4.41%)
-45.37M
(+11.15%)
-40.82M
(+18.77%)
-34.37M
(+19.17%)
-28.84M
(+28.75%)
-22.40M
(+13.71%)
-19.70M
(+18.75%)
-16.59M
(+2.09%)
-16.25M
(-2.58%)
-16.68M
(-2.06%)
-17.03M22M-22.43M
(+31.40%)
-17.07M
(+38.22%)
-12.35M
(+1.73%)
-12.14M
(-8.38%)
-13.25M
(+71.41%)
-7.73M
(-13.63%)
-8.95M
(+14.01%)
-7.85M
(+34.42%)
-5.84M
(+54.91%)
-3.77M
Other Income / Expenses
Interest Income
520K
(-42.22%)
900K
(-22.41%)
1.16M
(-27.50%)
1.60M
(-18.78%)
1.97M
(-9.22%)
2.17M
(-19.63%)
2.70M
(-7.85%)
2.93M
(-11.21%)
3.30M
(+2.48%)
3.22M
(+22.90%)
2.62M
(+40.11%)
1.87M
(+163.38%)
710K
(+144.83%)
290K
(+1350.00%)
20K
(-33.33%)
30K
(+50.00%)
20K
(+100.00%)
10K
(0.00%)
10K-20K
(-77.78%)
90K
(-70.97%)
310K-610K
(-16.44%)
730K
(+62.22%)
450K-340K
(-2.86%)
350K-910K-----
Interest Expense
390K
(-41.79%)
670K
(-14.10%)
780K
(-13.33%)
900K
(-9.09%)
990K
(+1.02%)
980K
(-2.00%)
1.00M
(-4.76%)
1.05M
(+2.94%)
1.02M
(0.00%)
1.02M
(+4.08%)
980K
(+2.08%)
960K
(+9.09%)
880K
(+15.79%)
760K
(+5.56%)
720K
(-26.53%)
980K
(+880.00%)
100K
(0.00%)
100K
(+11.11%)
90K-90K
(0.00%)
90K
(0.00%)
90K-110K
(+175.00%)
40K-----------
Net Interest Income
520K
(-42.22%)
900K
(-22.41%)
1.16M
(-55.38%)
2.60M
(+31.98%)
1.97M
(-9.22%)
2.17M
(+27.65%)
1.70M
(-9.57%)
1.88M
(-17.90%)
2.29M
(+4.57%)
2.19M
(+33.54%)
1.64M
(+82.22%)
900K-170.00K
(-63.83%)
-470.00K
(-33.80%)
-710.00K
(-25.26%)
-950.00K
(+1087.50%)
-80.00K
(-11.11%)
-90.00K
(+12.50%)
-80.00K--70.00K-220K-500K
(-27.54%)
690K
(+53.33%)
450K-340K
(-2.86%)
350K-910K-----
Other Non Operating Income
120K
(-45.45%)
220K
(-43.59%)
390K
(-91.45%)
4.56M
(+360.61%)
990K
(-16.81%)
1.19M
(-30.00%)
1.70M
(-78.75%)
8.00M
(+249.34%)
2.29M
(+4.57%)
2.19M
(+33.54%)
1.64M-440.00K
(+158.82%)
-170.00K
(-63.83%)
-470.00K
(-33.80%)
-710.00K
(-40.83%)
-1.20M
(+1400.00%)
-80.00K
(-11.11%)
-90.00K
(+12.50%)
-80.00K--70.00K-220K-500K
(-27.54%)
690K
(+53.33%)
450K-340K
(-2.86%)
350K
(-2.78%)
360K
(-60.44%)
910K
(+184.38%)
320K
(+100.00%)
160K
(+220.00%)
50K
(0.00%)
50K
(+150.00%)
20K
Net Income
Income Before Tax
-7.54M---57.69M
(+420.67%)
-11.08M---130.01M
(+212.07%)
-41.66M---204.21M-------------------------
Income Tax Expense
----420K--------------------------------
Net Income From Continuing Operations
-7.54M
(-68.97%)
-24.30M
(+0.75%)
-24.12M
(+70.82%)
-14.12M
(+22.78%)
-11.50M
(-52.62%)
-24.27M
(+25.69%)
-19.31M
(-1.18%)
-19.54M
(-53.10%)
-41.66M
(-23.29%)
-54.31M
(-3.29%)
-56.16M
(+25.02%)
-44.92M
(-24.90%)
-59.81M
(+14.53%)
-52.22M
(+10.50%)
-47.26M
(-3.51%)
-48.98M
(+7.72%)
-45.47M
(+11.15%)
-40.91M
(+17.93%)
-34.69M
(+20.28%)
-28.84M
(+28.23%)
-22.49M
(+13.64%)
-19.79M
(+16.89%)
-16.93M
(+4.18%)
-16.25M
(-3.22%)
-16.79M
(-1.64%)
-17.07M22M-22.43M
(+31.40%)
-17.07M
(+38.22%)
-12.35M
(-0.40%)
-12.40M
(-11.24%)
-13.97M
(+80.72%)
-7.73M
(-13.63%)
-8.95M
(+11.04%)
-8.06M
(+38.01%)
-5.84M
(+54.91%)
-3.77M
Net Income
-7.54M
(-68.97%)
-24.30M
(+0.75%)
-24.12M
(+70.82%)
-14.12M
(+22.78%)
-11.50M
(-52.62%)
-24.27M
(+25.69%)
-19.31M
(-1.18%)
-19.54M
(-53.10%)
-41.66M
(-23.29%)
-54.31M
(-3.29%)
-56.16M
(+25.02%)
-44.92M
(-24.90%)
-59.81M
(+14.53%)
-52.22M
(+10.50%)
-47.26M
(-3.51%)
-48.98M
(+7.72%)
-45.47M
(+11.15%)
-40.91M
(+17.93%)
-34.69M
(+20.28%)
-28.84M
(+28.23%)
-22.49M
(+13.64%)
-19.79M
(+16.89%)
-16.93M
(+4.18%)
-16.25M
(-3.22%)
-16.79M
(-1.64%)
-17.07M22M-22.43M
(+31.40%)
-17.07M
(+38.22%)
-12.35M
(-0.40%)
-12.40M
(-11.24%)
-13.97M
(+80.72%)
-7.73M
(-13.63%)
-8.95M
(+11.04%)
-8.06M
(+38.01%)
-5.84M
(+54.91%)
-3.77M
Comprehensive Income Net Of Tax
-7.54M
(-68.97%)
-24.30M
(+0.70%)
-24.13M
(-65.13%)
-69.19M
(+506.93%)
-11.40M
(-52.99%)
-24.25M
(+24.94%)
-19.41M
(-88.68%)
-171.51M
(+312.18%)
-41.61M
(-23.47%)
-54.37M
(-2.91%)
-56.00M
(-72.60%)
-204.36M
(+241.05%)
-59.92M
(+14.48%)
-52.34M
(+10.75%)
-47.26M
(-72.21%)
-170.06M
(+274.00%)
-45.47M
(+11.15%)
-40.91M
(+17.93%)
-34.69M--22.49M
(+13.70%)
-19.78M
(+16.70%)
-16.95M--16.77M
(-1.70%)
-17.06M22M--17.02M
(+38.60%)
-12.28M
(-1.13%)
-12.42M
(-68.04%)
-38.86M
(+402.07%)
-7.74M
(-13.52%)
-8.95M
(+11.04%)
-8.06M
(+38.01%)
-5.84M
(+54.91%)
-3.77M